MyoKardia (MYOK)

44.68 -0.40 (0.89%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/7/18 *Est.)

Latest Headlines

Form 4 MyoKardia Inc For: Jan 07 Filed by: GIANAKAKOS ANASTASIOS January 11, 2019 8:20 PM - SEC Filing Form 4 MyoKardia Inc For: Jan 07 Filed by: Lee June January 9, 2019 9:37 PM - SEC Filing Form 4 MyoKardia Inc For: Jan 07 Filed by: Semigran Marc January 9, 2019 9:33 PM - SEC Filing Form 4 MyoKardia Inc For: Jan 07 Filed by: Bauer Jake January 9, 2019 9:23 PM - SEC Filing Form 4 MyoKardia Inc For: Jan 07 Filed by: Lambing Joseph January 9, 2019 9:20 PM - SEC Filing Form 4 MyoKardia Inc For: Jan 07 Filed by: McDowell Robert Scott January 9, 2019 9:16 PM - SEC Filing Form 4 MyoKardia Inc For: Jan 04 Filed by: GIANAKAKOS ANASTASIOS January 8, 2019 7:13 PM - SEC Filing MyoKardia (MYOK) PT Lowered to $71 at Credit Suisse January 4, 2019 8:53 AM - StreetInsider Form 4 MyoKardia Inc For: Jan 01 Filed by: Semigran Marc January 3, 2019 9:59 PM - SEC Filing Form 4 MyoKardia Inc For: Jan 01 Filed by: Lambing Joseph January 3, 2019 9:46 PM - SEC Filing Form 4 MyoKardia Inc For: Jan 01 Filed by: Lee June January 3, 2019 9:42 PM - SEC Filing Form 4 MyoKardia Inc For: Jan 01 Filed by: Bauer Jake January 3, 2019 9:40 PM - SEC Filing Form 4 MyoKardia Inc For: Jan 01 Filed by: McDowell Robert Scott January 3, 2019 9:38 PM - SEC Filing Form 4 MyoKardia Inc For: Jan 01 Filed by: GIANAKAKOS ANASTASIOS January 3, 2019 9:38 PM - SEC Filing MyoKardia to Present at 37th Annual J.P. Morgan Healthcare Conference January 3, 2019 8:00 AM - Globe NewsWire Form 8-K MyoKardia Inc For: Dec 31 January 2, 2019 4:18 PM - SEC Filing MyoKardia (MYOK) PT Raised to $84 at Wedbush January 2, 2019 2:18 PM - StreetInsider MyoKardia (MYOK) Re-acquires Global Rights to Mavacamten and MYK-491 Programs from Sanofi (SNY) January 2, 2019 8:13 AM - StreetInsider MyoKardia Regains Global Rights to Mavacamten and MYK-491 Programs from Sanofi January 2, 2019 8:00 AM - Globe NewsWire Form 4 MyoKardia Inc For: Oct 31 Filed by: Lambing Joseph December 20, 2018 9:32 PM - SEC Filing Form 4 MyoKardia Inc For: Oct 31 Filed by: Semigran Marc December 20, 2018 9:25 PM - SEC Filing Form 4 MyoKardia Inc For: Dec 12 Filed by: GIANAKAKOS ANASTASIOS December 13, 2018 8:42 PM - SEC Filing MyoKardia (MYOK) Announces Positive Data from Phase 1b Single-Ascending Dose Clinical Trial of MYK-491 in Dilated Cardiomyopathy and Systolic Heart Failure Patients December 11, 2018 8:34 AM - StreetInsider MyoKardia Reports Positive Data from Phase 1b Single-Ascending Dose Clinical Trial of MYK-491 in Dilated Cardiomyopathy and Systolic Heart Failure Patients December 11, 2018 8:30 AM - Globe NewsWire Form 4 MyoKardia Inc For: Oct 31 Filed by: Lee June December 6, 2018 8:15 PM - SEC Filing MyoKardia to Present at the BMO 2018 Prescriptions for Success Healthcare Conference December 5, 2018 4:01 PM - Globe NewsWire Consolidated Research: 2018 Summary Expectations for MyoKardia, Bristow Group, The Chefs' Warehouse, Catabasis Pharmaceuticals, Casa, and EP Energy — Fundamental Analysis, Key Performance Indic November 28, 2018 8:55 AM - Globe NewsWire Baker Bros. Advisors 13F for Quarter Ended Sept. 30, 2018 November 14, 2018 4:55 PM - StreetInsider MyoKardia (MYOK) Presents Preclinical Evidence of Mavacamten's Novel Effect on Diastolic Compliance at AHA November 12, 2018 7:33 AM - StreetInsider MyoKardia Presents Preclinical Evidence of Mavacamten’s Novel Effect on Diastolic Compliance at the 2018 American Heart Association Scientific Sessions November 12, 2018 7:30 AM - Globe NewsWire Form 10-Q MyoKardia Inc For: Sep 30 November 8, 2018 12:48 PM - SEC Filing Form 8-K MyoKardia Inc For: Nov 07 November 7, 2018 4:55 PM - SEC Filing MyoKardia Reports Third Quarter 2018 Financial Results November 7, 2018 4:30 PM - Globe NewsWire MyoKardia to Present at the Credit Suisse 27th Annual Healthcare Conference November 7, 2018 8:01 AM - Globe NewsWire Form 4 MyoKardia Inc For: Oct 31 Filed by: GIANAKAKOS ANASTASIOS November 6, 2018 7:33 PM - SEC Filing Form 4 MyoKardia Inc For: Oct 31 Filed by: Bauer Jake November 6, 2018 7:31 PM - SEC Filing MyoKardia to Present Clinical Evidence of Mavacamten’s Effect on Diastolic Function at 2018 American Heart Association Scientific Sessions November 5, 2018 8:01 AM - Globe NewsWire MyoKardia Announces Twelve Abstracts Accepted for Presentation During the 2018 American Heart Association Scientific Sessions November 5, 2018 8:01 AM - Globe NewsWire MyoKardia (MYOK) Ticks Higher Ahead of CEO Mad Money Interview October 30, 2018 11:50 AM - StreetInsider MyoKardia Shares Data from Ongoing Clinical Programs and Details Three New Research Programs at 2018 R&D Day October 30, 2018 7:30 AM - Globe NewsWire MyoKardia Announces Initiative to Create Hypertrophic Cardiomyopathy Patient Community in Collaboration with 23andMe October 25, 2018 12:00 AM - Globe NewsWire MyoKardia Doses First Patient in MAVA Long-Term Extension Study of Mavacamten for Hypertrophic Cardiomyopathy October 24, 2018 4:30 PM - Globe NewsWire MyoKardia to Host R&D Day on October 30, 2018 October 22, 2018 8:30 AM - Globe NewsWire Full Article List